STRIVE
LIVE

Serial Number

98975541

Owner

Embecta Corp.

Attorney

STEPHEN R. BAIRD

Filing Date

Jul 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

STRIVE Trademark

Serial Number: 98975541

STRIVE is a trademark filed by Embecta Corp. on July 18, 2023. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Embecta Corp.

300 Kimball Drive, Suite 300
Parsippany, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

July 18, 2023

Registration Date

Not Registered

Published for Opposition

March 3, 2026

Goods & Services

Medical devices and apparatus in the field of diabetes, namely, medical devices and apparatus for measuring blood glucose levels and injecting insulin; Medical devices and medical apparatus in the field of diabetes, namely, medical devices for monitoring blood glucose levels and administering insulin therapy; Medical devices, namely, diabetes management devices in the nature of insulin pumps, blood glucose monitors, infusion pumps, infusion pump controllers and structural and replacement parts therefor; Medical devices and medical apparatus in the field of diabetes, namely, patch pumps for administering continuous subcutaneous insulin infusion for insulin therapy; Medical devices and medical apparatus in the field of diabetes, namely, wearable subcutaneous drug delivery devices, sold empty, in the nature of on-body injectors, insulin injectors, infusion pumps, insulin pumps, patch pumps, and controllers, and structural and replacement parts therefor; Medical venous access ports; lancets; needles for medical use; syringes for medical use; Pen needles used to deliver medications to manage diabetes; Infusion sets; Infusion pump accessories, namely, belt clips specifically designed for holding infusion pumps and infusion sets; Subcutaneous infusion sets for use by diabetes patients in connection with insulin pumps; Infusion pumps; Insulin pumps; Infusion and insulin pump accessories, namely, medical sensors, meters, and medical devices for measuring and monitoring blood and urine properties; Medical devices and medical apparatus for measuring and monitoring blood and urine properties; Glucose meters; Blood glucose meters; Medical apparatus for monitoring blood glucose levels; Medical apparatus and instruments for monitoring glucose; Continuous glucose monitoring systems comprised of a medical apparatus for monitoring glucose; Sensor-based glucose monitors for medical purposes; Blood glucose monitoring systems, namely, blood glucose monitors, and parts and accessories therefor, namely, blood glucose monitoring carrying cases, and electronic blood glucose test diaries in the nature of integrated computer memory devices within blood glucose monitors; Devices for monitoring blood glucose for medical purposes; Devices for measuring blood sugar; Medical devices, namely, medical sensors that are implanted and inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, data receivers, sensor housings and sensor insertion devices; Medical diagnostic apparatus for testing blood sugar levels incorporating recorded software for the collection, editing, organizing, modifying, transmission, storage and sharing of medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for controlling and managing patient medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for acquiring, analyzing, transmitting and storing medical and physiological data; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for linking medical instruments and devices for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for providing nonmedical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of blood glucose monitors incorporating computer hardware and recorded software for monitoring blood glucose in connection with blood glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of insulin pumps incorporating computer hardware and recorded software for controlling insulin delivery in connection with insulin pumps; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps, and blood glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for obtaining, controlling, and managing patient medical information on wearable medical devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for controlling and managing wearable insulin delivery devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software used to display, manage, and monitor diabetes management information

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 9, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 9, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 9, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 9, 2026 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 2, 2026 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 28, 2025 PBCR
EXPARTE APPEAL TERMINATED
Oct 3, 2025 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 22, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 22, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 22, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 22, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2025 CRFA
ASSIGNED TO LIE
Sep 16, 2025 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 5, 2025 ERFR
EX PARTE APPEAL-INSTITUTED
Sep 5, 2025 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 5, 2025 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 5, 2025 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 30, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 8, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 8, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 8, 2025 CNFR
DIVISIONAL PROCESSING COMPLETE
Feb 12, 2025 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 12, 2025 AITU
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 4, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 4, 2024 XELR
DIVISIONAL REQUEST RECEIVED
May 16, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
May 16, 2024 ERTD
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2023 NWOS
NEW APPLICATION ENTERED
Jul 21, 2023 NWAP